Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Biden Team to Use DPA for Vaccine Manufacturing, Testing

Feb. 5, 2021, 4:47 PM

The Biden administration announced plans Friday to use the Defense Production Act to boost supplies for manufacturing of Pfizer Inc.’s Covid-19 vaccine and to ramp up availability of at-home virus tests.

Priority ratings will give Pfizer first access to raw materials, allowing the company to increase manufacturing and meet its delivery targets, Tim Manning, Covid-19 supply coordinator, said at a White House briefing.

Six new companies also will surge production of at-home tests to make more than 60 million such tests available by the summer, according to Manning.

“This amounts to the first sequence of actions under the ...